by TractManager | Apr 25, 2023 | Health Technology Assessment
Focus of the Report: The focus of this Health Technology Assessment is evaluation of the effectiveness and safety of prostatic artery embolization (PAE) compared with open prostatectomy and minimally invasive approaches to treat moderate-to-severe benign prostatic...
by TractManager | Apr 14, 2023 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Luminopia One (Luminopia Inc.) for the treatment of amblyopia in children aged 4 to 7 years to improve visual...
by TractManager | Apr 13, 2023 | Emerging Technology Report
Blarcamesine (ANAVEX 2-73) is an investigational oral drug that targets sigma-1 and muscarinic receptors. It is in development for the treatment of Rett syndrome as well as for a number of other central nervous system disorders.If you have a Hayes login, click here to...
by TractManager | Apr 4, 2023 | Health Technology Assessment
Focus of the Report: The focus of this Health Technology Assessment is to evaluate the effectiveness and safety of maintenance repetitive transcranial magnetic stimulation (rTMS) compared with sham rTMS, pharmacotherapy, or combination therapy to prevent the...
Recent Comments